Project Grant R44FD007584

Award Date 9/27/22
Completion Date 8/31/25
Dollars Obligated $1.2M
Funding Federal Agency
Office of the Commissioner
Federal Grant Program
93.103
Assistance Type
Project Grant
Place of Performance
Newark, CA 94560, USA
Similar Awards
This $1,063,155 Project Grant awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) aims to develop and test a novel quality assurance (QA) device for advanced radiation therapy techniques. The device, named the RetrieveTM, will enable more precise, efficient, and comprehensive QA compared to existing solutions. The project seeks to: 1) refine the hardware to measure machine performance metrics to within 0.5 mm and 1% relative dose,...
Sterile Geeks VR Inc. was awarded a $254,718 Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop mixed reality wearable technology solutions to improve workflow, productivity, and training for medical sterilization technicians. The award period is from September 1, 2022 to August 31, 2023. The company will create augmented reality applications and software to enhance job performance for sterile processing...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to M3D, Inc. will develop a novel gamma ray radiation imager for image-guided tumor diagnostics. The project aims to characterize the design parameters and optimize the collimation and image reconstruction techniques to produce fast, high-resolution images suitable for radio-guided lymph node biopsy and resection procedures. The goal is to demonstrate proof-of-principle...
This $644,622 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to the Regents of the University of Michigan will develop tools and predictive models to enable dosimetry-guided radiopharmaceutical therapy (RPT) for metastatic castrate resistant prostate cancer (mCRPC). The key objectives are to: 1) develop a novel method for bone marrow dosimetry using macro/micro Monte Carlo modeling; 2) build models to predict absorbed dose from pre-therapy PET...
This Project Grant award of $161,000.00 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program aims to develop a surgical probe prototype specifically designed for use with PET radiotracers during laparoscopic prostate cancer resection procedures. The key innovation is the use of two back-to-back detectors with high energy resolution to select...
This Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), aims to develop a rapid, inexpensive microfluidics-based approach for dose-on-demand production of ready-to-inject radiopharmaceuticals. The $1,149,264 award to the University of Texas MD Anderson Cancer Center will fund the development of a...
Radiabeam Systems, LLC received a $199,597 Project Grant award from the Department of Energy Office of Science on June 28, 2021 to support development of a tunable electronic brachytherapy system. The award was made under the Office of Science Financial Assistance Program (CFDA 81.049), which aims to deliver scientific discoveries and tools to transform understanding of nature and advance U.S. energy and economic security. The grant funded Radiabeam Systems to develop a brachytherapy device that...
The National Cancer Institute (NCI) awarded a $898,497 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Radiopharmaceutical Imaging and Dosimetry, LLC (RAPID) for the development of a cloud-based, customer-responsive dosimetry tool for alpha-particle emitting radiopharmaceutical therapies. The funding will enable RAPID to build upon its previous work and transition from a radiological protection-based dosimetry paradigm to one focused on normal tissue...
Skyhaven Systems, LLC received a $255,998 Project Grant award from the National Science Foundation Division of Industrial Innovation on August 15, 2021 to complete work by January 31, 2022. The grant funds the development of desktop plug-and-play vaporized hydrogen peroxide sterilizers for personal protective equipment as part of the NSF Engineering program (CFDA 47.041). The Engineering program supports innovation, creativity, and excellence in engineering research and education to improve...
This Project Grant award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research program) provides $596,095 to the University of Washington to develop and validate a portable, patient-friendly radiation measurement device called the Personalized Remote Radiation Tracking Portable Organ Dosimetry Device (PRRT PODD or PODD). The PODD aims to enable personalization of 177Lu-DOTATATE targeted radionuclide therapy for neuroendocrine tumor patients by allowing them to remotely...

VIRTUAL DOSE MAPPING FOR RADIATION STERILIZATION - PROJECT SUMMARY THIS GRANT IS IN RESPONSE TO PA-22-176, AN OMNIBUS CALL FROM NIH, FDA, AND CDC. THEREIN THE FDA EXPRESSES THE NEED TO DEVELOP COMPUTER MODELLING TOOLS THAT HELP WITH REGULATORY DECISION MAKING. STERILIZATION IS THE TERMINAL STEP OF MEDICAL DEVICE DEVELOPMENT, AND STERILIZATION VALIDATION IS A REGULATORY RE- QUIREMENT. WE ARE DEVELOPING A MONTE CARLO MODELLING TOOL THAT CAN PRODUCE VIRTUAL DOSE MAPS FOR RADIATION STERILIZATION, THEREBY HELPING MEDICAL COMPANIES MAKE IMPORTANT DECISIONS ABOUT STERILIZATION THAT WILL ALSO AFFECT THE REGULATORY PATHWAY EARLY IN THE MEDICAL DEVICE DEVELOPMENT CYCLE. AS MODELLING ONLY REQUIRES A CAD MODEL OF THE DEVICE AND NOT A MANUFACTURED DEVICE (WHICH IS REQUIRED FOR DOSE MAPPING AT A CONTRACT STERILIZER), MOD- ELLING CAN BE USED EARLY TO ITERATE ON THE DESIGN OF THE DEVICE AND ITS PACKING. SUCH A MODELLING TOOL WILL ALLOW MEDICAL DEVICE COMPANIES TO SHORTEN AND DE-RISK THE DESIGN PROCESS WITH RESPECT TO STERILIZATION. MONTE CARLO MODELLING LIBRARIES SUCH AS GEANT4 HAVE THE ABILITY TO ACCURATELY MODEL RADIATION TRANSPORT AND DOSE DEPOSITION. BECAUSE OF THIS, GEANT4 IS WIDELY USED IN HIGH ENERGY PHYSICS AND RADIATION TREATMENT, BUT SO FAR IT IS RARELY USED FOR RADIATION STERILIZATION. THE REASON FOR THIS IS THE LACK OF USER FRIENDLINESS, WHICH STEMS FROM ITS FLEXIBLE ARCHITECTURE AND THE SLOW SIMULATION SPEEDS. FURTHERMORE, GEANT4 DOES NOT PROVIDE THE ABILITY TO LOAD FULL CAD MODELS, AND THUS MAKES IT RATHER CUMBERSOME TO MODEL ENTIRE MEDICAL DEVICES. IN PHASE I OF THIS FDA SBIR GRANT, WE SHOWED THAT GEANT4 CAN BE DEPLOYED IN THE CLOUD. WE HAVE DEVELOPED A PROTOTYPE OF A WEB USER INTERFACE TO CONFIGURE SIMULATIONS AND TO REVIEW MODELED RESULTS. OUR CLOUD TOOL CAN LOAD FULL CAD MODELS AND ACCURATELY REPRODUCE MEASURED DOSE MAPS. WE SHOWED A 100X INCREASE OF SIMULATION SPEED COMPARED TO A SINGLE COMPUTER DUE TO SEAMLESS SCALING IN THE CLOUD. IN PHASE II WE WILL BUILD ON OUR ACCOMPLISHMENTS OF PHASE I AND EXTEND THIS TOOL TO BE CAPABLE OF MODELING DOSE MAPS FROM X-RAY AND GAMMA STERILIZATION. WE WILL DEVELOP PARAMETRIC RADIATION SOURCE MODELS THAT CAN BE CALI- BRATED WITH QUALIFICATION DATA PROVIDED BY THE CONTRACT STERILIZER. WE WILL REFINE OUR USER INTERFACE AND GIVE THE USER THE ABILITY TO COMPARE THE DIFFERENT RADIATION STERILIZATION TECHNOLOGIES. WE WILL ALSO IMPLEMENT THE ABILITY TO MODEL VIRTUAL DOSIMETERS TO FACILITATE DIRECT COMPARISON WITH MEASUREMENTS. IN USER STUDIES WE WILL SHOW THAT THE TOOL IS USER-FRIENDLY AND CAN BE USED TO STREAMLINE DECISIONS NECESSARY FOR REGULATORY FILINGS. OUR MODELLING TOOL WILL BE GEARED TOWARDS ENGINEERS AT MEDICAL DEVICE COMPANIES AND DOES NOT REQUIRE AN ADVANCED BACKGROUND IN SOFTWARE ENGINEERING OR RADIATION PHYSICS. RATHER, THE ENGINEER WILL BE GUIDED THROUGH SIMPLE STEPS THROUGH THE SIMULATION PROCESS. THE ENGINEER CAN REVIEW THE RESULTS IN A USER-FRIENDLY VIEWER AND DETERMINE THE DOSE UNIFORMITY RATIO. WE ANTICIPATE THAT OUR TOOL WILL OFFER SIGNIFICANT BENEFITS TO THE MEDICAL DEVICE DEVELOPMENT COMMUNITY.

Posted 9/29/23, 12:00 AM